| Product |
CAS |
Molecular formula |
More |
| 3-((3S,4r)-4-methyl-3-(methyl(7h-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pi |
1092578-48-7 |
C16H20N6O |
More |
| Ethyl 4-(2,3,4-trimethoxybenzyl)piperazine-1-carboxylate |
53531-01-4 |
C17H26N2O5 |
More |
| 3,5-Pyridinedicarboxylic acid,4-(2-chlorophenyl)-2-[[2-(1,3-dihydro-1, |
140171-50-2 |
C27H25ClN2O7 |
More |
| (2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carboxyli |
565453-40-9 |
C17H26N2O4 |
More |
| 2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amin |
284461-74-1 |
C20H14ClF3N4O3 |
More |
| D-phenylalanine, n-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-, met |
105746-47-2 |
C20H29NO3 |
More |
| 1(2H)-phthalazinone,4-[(4-chlorophenyl)methyl]-2-[(4s)-hexahydro-1-met |
143228-85-7 |
C22H24 Cl N3 O |
More |
| 1H-benzimidazole,2-[(r)-[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]me |
177795-60-7 |
C18H21N3O3S |
More |
| (3R,5s,6r,7r,10s,13r)-6-ethyl-17-((r)-5-hydroxypentan-2-yl)-10,13-dime |
1537866-49-1 |
C22H29FO5 |
More |
| (R)-4-((3r,5s,6s,7r,10s,13r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-hexa |
915038-27-6 |
C22H29FO5 |
More |
| Bibf 1202 |
894783-71-2 |
C30H31N5O4 |
More |
| 6-O-desmethoxyethyl-6-o-chloroethyl erlotinib hydrochloride |
183320-04-9 |
C21H21Cl2N3O3 |
More |
| 7-O-desmethoxy-7-o-chloroethyl erlotinib hydrochloride |
183320-19-6 |
C21H21Cl2N3O3 |
More |
| 1-Cyclopropyl-7-8-difluoro-6-methoxy-4-oxo-1,4-dihydroquinoline-3-carb |
1329836-33-0 |
C16H15F2NO4 |
More |
| 6-Cyclopropyl-8,9-difluoro-7-methoxy-4-oxo-4,6-dihydro-2h-1l3-[1,3]dio |
139693-52-0 |
C22H29FO5 |
More |
| Ethyl n-((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-n-pentanoyl |
1111177-30-0 |
C26H33N5O3 |
More |
| S)-2-(((2-(1h-tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)amino)-3-methy |
676129-92-3 |
C19H21N5O2 |
More |
| N-desmethyl rosuvastatin-d3 |
371775-74-5 |
C21H23D3FN3O6S |
More |
| Diethyl 2,6-bis((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydrop |
331258-31-2 |
C22H29FO5 |
More |
| Vildagliptin impurity k |
565453-39-6 |
C17H26N2O4 |
More |